SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘State Opioid Response 
Grant Authorization Act of 2021’’. 
SEC. 2. GRANT PROGRAM FOR STATE AND TRIBAL RE-
SPONSE TO OPIOID AND STIMULANT USE AND 
MISUSE. 
Section 1003 of the 21st Century Cures Act (42 
U.S.C. 290ee–3 note) is amended to read as follows: 
‘‘SEC. 1003. GRANT PROGRAM FOR STATE AND TRIBAL RE-
SPONSE TO OPIOID AND STIMULANT USE AND 
MISUSE. 
‘‘(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this section as the ‘Sec-
retary’) shall carry out the grant program described in 
subsection (b) for purposes of addressing opioid and stim-
ulant use and misuse, within States, Indian Tribes, and 
populations served by Tribal organizations and Urban In-
dian organizations. 
‘‘(b) GRANTS PROGRAM.— 
‘‘(1) IN GENERAL.—Subject to the availability 
of appropriations, the Secretary shall award grants 
to States, Indian Tribes, Tribal organizations, and 
Urban Indian organizations for the purpose of ad-
dressing opioid and stimulant use and misuse, within 
such States, such Indian Tribes, and populations 
served by such Tribal organizations and Urban In-
dian organizations, in accordance with paragraph 
(2). 
‘‘(2) MINIMUM ALLOCATIONS; PREFERENCE.— 
In determining grant amounts for each recipient of 
a grant under paragraph (1), the Secretary shall— 
‘‘(A) ensure that each State receives not 
less than $4,000,000; and 
‘‘(B) give preference to States, Indian 
Tribes, Tribal organizations, and Urban Indian 
organizations whose populations have an inci-
dence or prevalence of opioid use disorders or 
stimulant use or misuse that is substantially 
higher relative to the populations of other 
States, other Indian Tribes, Tribal organiza-
tions, or Urban Indian organizations, as appli-
cable. 
‘‘(3) FORMULA METHODOLOGY.— 
‘‘(A) IN
GENERAL.—Before publishing a 
funding opportunity announcement with respect 
to grants under this section, the Secretary 
shall— 
‘‘(i) develop a formula methodology to 
be followed in allocating grant funds 
awarded under this section among grant-
ees, which includes performance assess-
ments for continuation awards; and 
‘‘(ii) not later than 30 days after de-
veloping the formula methodology under 
clause (i), submit the formula methodology 
to— 
‘‘(I) the Committee on Energy 
and Commerce and the Committee on 
Appropriations of the House of Rep-
resentatives; and 
‘‘(II) the Committee on Health, 
Education, Labor, and Pensions and 
the Committee on Appropriations of 
the Senate. 
‘‘(B) REPORT.—Not later than two years 
after the date of the enactment of the State 
Opioid Response Grant Authorization Act of 
2021, the Comptroller General of the United 
States shall submit to the Committee on 
Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Com-
merce of the House of Representatives a report 
that— 
‘‘(i) assesses how grant funding is al-
located to States under this section and
how such allocations have changed over 
time; 
‘‘(ii) assesses how any changes in 
funding under this section have affected 
the efforts of States to address opioid or 
stimulant use or misuse; and 
‘‘(iii) assesses the use of funding pro-
vided through the grant program under 
this section and other similar grant pro-
grams administered by the Substance 
Abuse and Mental Health Services Admin-
istration. 
‘‘(4) USE OF FUNDS.—Grants awarded under 
this subsection shall be used for carrying out activi-
ties that supplement activities pertaining to opioid 
and stimulant use and misuse, undertaken by the 
State agency responsible for administering the sub-
stance abuse prevention and treatment block grant 
under subpart II of part B of title XIX of the Public 
Health Service Act (42 U.S.C. 300x–21 et seq.), 
which may include public health-related activities 
such as the following: 
‘‘(A) Implementing prevention activities, 
and evaluating such activities to identify effec-
tive strategies to prevent substance use dis-
orders. 
‘‘(B) Establishing or improving prescrip-
tion drug monitoring programs. 
‘‘(C) Training for health care practitioners, 
such as best practices for prescribing opioids, 
pain management, recognizing potential cases 
of substance use disorders, referral of patients 
to treatment programs, preventing diversion of 
controlled substances, and overdose prevention. 
‘‘(D) Supporting access to health care 
services, including— 
‘‘(i) services provided by federally cer-
tified opioid treatment programs; 
‘‘(ii) outpatient and residential sub-
stance use disorder treatment services that 
utilize medication-assisted treatment, as 
appropriate; or 
‘‘(iii) other appropriate health care 
providers to treat substance use disorders. 
‘‘(E) Recovery support services, includ-
ing— 
‘‘(i) community-based services that in-
clude peer supports;
‘‘(ii) mutual aid recovery programs 
that support medication-assisted treat-
ment; or 
‘‘(iii) services to address housing 
needs and family issues. 
‘‘(F) Other public health-related activities, 
as the State, Indian Tribe, Tribal organization, 
or Urban Indian organization determines appro-
priate, related to addressing substance use dis-
orders within the State, Indian Tribe, Tribal or-
ganization, or Urban Indian organization, in-
cluding directing resources in accordance with 
local needs related to substance use disorders. 
‘‘(c) ACCOUNTABILITY AND OVERSIGHT.—A State re-
ceiving a grant under subsection (b) shall include in re-
porting related to substance use disorders submitted to the 
Secretary pursuant to section 1942 of the Public Health 
Service Act (42 U.S.C. 300x–52), a description of— 
‘‘(1) the purposes for which the grant funds re-
ceived by the State under such subsection for the 
preceding fiscal year were expended and a descrip-
tion of the activities of the State under the grant; 
‘‘(2) the ultimate recipients of amounts pro-
vided to the State; and